NKX3.1 contributes to S phase entry and regulates DNA damage response (DDR) in prostate cancer cell lines. [electronic resource]
- Biochemical and biophysical research communications Oct 2011
- 123-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1090-2104
10.1016/j.bbrc.2011.09.035 doi
Androgens--pharmacology Camptothecin--analogs & derivatives Cell Line, Tumor DNA Damage Histones--pharmacology Homeodomain Proteins--genetics Humans Irinotecan Male Prostatic Neoplasms--genetics S Phase Transcription Factors--genetics